PubRank

Jong Woo Lee

Author PubWeight™ 50.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J 2011 1.65
2 Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007 1.62
3 Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003 1.56
4 Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg 2013 1.46
5 Use of modafinil in patients with epilepsy. Epilepsy Behav 2012 1.42
6 Somatic mutations of the ERBB4 kinase domain in human cancers. Int J Cancer 2006 1.38
7 BRAF and KRAS mutations in stomach cancer. Oncogene 2003 1.27
8 A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011 1.22
9 CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005 1.20
10 Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch 2005 1.20
11 Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene 2005 1.09
12 Loss of caspase-2, -6 and -7 expression in gastric cancers. APMIS 2004 1.06
13 Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 2003 1.05
14 Somatic mutations of CASP3 gene in human cancers. Hum Genet 2004 1.05
15 Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. Oncology 2006 1.00
16 Propagation of epileptic spikes reconstructed from spatiotemporal magnetoencephalographic and electroencephalographic source analysis. Neuroimage 2009 0.98
17 Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene 2003 0.96
18 Primary Classic Kaposi's Sarcoma of the Penis in an HIV-Negative Patient. Korean J Urol 2010 0.95
19 Absence of MLL3 mutations in colorectal carcinomas of Korean patients. APMIS 2007 0.93
20 ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas. Int J Cancer 2006 0.92
21 Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer. Oncogene 2002 0.92
22 The utility of conductive plastic electrodes in prolonged ICU EEG monitoring. Neurocrit Care 2008 0.88
23 Inactivating mutation of the pro-apoptotic gene BID in gastric cancer. J Pathol 2004 0.88
24 Carotid dissection in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes. J Neurol 2010 0.87
25 A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003 0.86
26 Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer. Int J Cancer 2005 0.86
27 Colorectal tumors frequently express phosphorylated mitogen-activated protein kinase. APMIS 2004 0.85
28 Expression and immunohistochemical localization of TMEM16A/anoctamin 1, a calcium-activated chloride channel in the mouse cochlea. Cell Tissue Res 2011 0.83
29 Immunohistochemical and mutational analysis of apoptosis-inducing factor (AIF) in colorectal carcinomas. APMIS 2006 0.83
30 Diurnal pattern of seizures outside the hospital: is there a time of circadian vulnerability? Neurology 2012 0.82
31 Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav 2010 0.82
32 Mutational analysis of Noxa gene in human cancers. APMIS 2003 0.81
33 BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder. Pathology 2006 0.81
34 Mutational analysis of PDPK1 kinase domain in gastric, colorectal and lung carcinomas. Acta Oncol 2006 0.80
35 Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. APMIS 2006 0.80
36 Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers. Pathol Res Pract 2007 0.80
37 Kinase domain mutation of ERBB family genes is uncommon in acute leukemias. Leuk Res 2005 0.79
38 Absence of GNAS and EGFL6 mutations in common human cancers. Pathology 2008 0.78
39 Mitochondrial microsatellite instability of colorectal cancer stroma. Int J Cancer 2006 0.78
40 Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas. J Neurooncol 2012 0.78
41 Mutational analysis of the kinase domain of MYLK2 gene in common human cancers. Pathol Res Pract 2006 0.78
42 Current dipole orientation and distribution of epileptiform activity correlates with cortical thinning in left mesiotemporal epilepsy. Neuroimage 2010 0.78
43 Somatic mutation of pro-apoptosis caspase-6 gene is rare in breast and lung carcinomas. Pathology 2006 0.77
44 Absence of DKC1 exon 3 mutation in common human cancers. Acta Oncol 2006 0.77
45 Quantitative EEG in hospital encephalopathy: review and microstate analysis. J Clin Neurophysiol 2013 0.77
46 Seizure control: a secondary benefit of chemotherapeutic temozolomide in brain cancer patients. Epilepsy Res 2011 0.76
47 Absence of JAK2 V617F mutation in gastric cancers. Acta Oncol 2006 0.76
48 Levetiracetam versus phenytoin: a comparison of efficacy of seizure prophylaxis and adverse event risk following acute or subacute subdural hematoma diagnosis. Neurocrit Care 2014 0.76
49 Nonconvulsive Seizures and Periodic Discharges: No Longer Such Innocent Bystanders. Epilepsy Curr 2016 0.75
50 Fruitful Futility: What We Learned From a Failed Clinical Trial of Out-of-Hospital Status Epilepticus Trial. Epilepsy Curr 2016 0.75
51 Methylphenidate: Brain Gain for the Epilepsy Drain. Epilepsy Curr 2017 0.75
52 Frontal Focal Cortical Dysplasias: Too Thin Here, Too Thick There, and the Folding Just Isn't Right! Epilepsy Curr 2016 0.75
53 Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer. APMIS 2003 0.75
54 Defining and Validating the Salzburg Criteria: It's Complicated. Epilepsy Curr 2017 0.75
55 Effects of thermal annealing on Pt-shell/MgO-core nanowires. J Nanosci Nanotechnol 2009 0.75
56 Delayed Seizures and Poor Functional Outcome After Intracranial Hemorrhage Is the Fate of Patients with a Poor Underlying Substrate, Say the Intensivists. Epilepsy Curr 2017 0.75
57 Absence of the ERBB2 kinase domain mutation in lung adenocarcinomas in Korean patients. Int J Cancer 2005 0.75
58 Mutating Our Understanding of Brain Tumors and Seizures: Entrez IDH. Epilepsy Curr 1 0.75
59 Absence of the BH3 domain mutation of proapoptotic Bcl-2 family gene BAD in serous and mucinous tumors of ovary. Gynecol Oncol 2006 0.75
60 Mutational analysis of salvador gene in human carcinomas. APMIS 2003 0.75
61 Kinase domain mutation of NTRK3 gene is uncommon in gastric carcinomas. Acta Oncol 2005 0.75
62 Seizures and antiepileptic drugs in patients with spontaneous intracerebral hemorrhages. Seizure 2013 0.75
63 Absence of fusion of TMPRSS2 and ETS transcription factor genes in gastric and colorectal carcinomas. APMIS 2007 0.75
64 Mutational analysis of P-loop domains of proapoptotic Nod1 and ARTS genes in colon carcinomas. Acta Oncol 2006 0.75
65 Effect of surface roughness on the subsequent growth of MgO nanowires. J Nanosci Nanotechnol 2008 0.75
66 hCDC4 gene mutation is rare in colorectal carcinomas in Korean patients. Pathology 2008 0.75
67 Sn-catalyzed growth of MgO nanowires. J Nanosci Nanotechnol 2007 0.75
68 Mutational analysis of Fas ligand gene in human non-Hodgkin lymphoma. APMIS 2003 0.75
69 Fabrication of gold nanotubes from removable MgO nanowires templates. J Nanosci Nanotechnol 2008 0.75
70 Kinase domain mutation of MAP2K4 is rare in gastric, colorectal and lung carcinomas. Pathology 2006 0.75
71 Mutation of FADD gene is rare in human colon and stomach cancers. APMIS 2004 0.75
72 Antiemetic properties of the antiepileptic drug levetiracetam. N Engl J Med 2008 0.75
73 Variation of ZnO shell thickness and its effects on the characteristics of coaxial nanowires. Nanotechnology 2008 0.75
74 Absence of the mutation of serine/threonine kinase genes AKT2 and MYLK2 in acute leukemias. Eur J Haematol 2006 0.75